S.A.C. Capital Advisors, a $6 billion hedge fund manager that controls a 9.5 stake in medical devices maker Inamed Corp. (IMDC.O: Quote, Profile, Research), on Thursday said it was undecided as to whether to support Allergan Inc.’s (AGN.N: Quote, Profile, Research) $3.2 billion offer for the company.
S.A.C., which is managed by Steven A. Cohen, said in a regulatory filing that it is “reviewing” Allergan’s offer, but that it has not decided whether to support it.
Irvine, California-based Allergan offered to buy Inamed for $84 in cash or .8498 of a share of Allergan stock.
